SRF Limited (SRF)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 15 July 2026
₹2,775.6 ↓ 13.9% (1Y)

🎯 Key Takeaways

  • SRF Limited is navigating a phase of strategic consolidation and leadership continuity amid fluctuating profitability. The company has demonstrated strong operational momentum with recent profit growth, yet faces elevated valuation multiples relative to peers.
  • Revenue grew 2% QoQ to ₹3,491 in Q3FY25.
  • ⚠️ Elevated valuation (P/E of 69.5) relative to sector peers may limit upside despite strong earnings.
Market Cap
₹79,723
P/E Ratio
69.5
Div Yield
0.00%
Promoter
0.0%

📖 The Story

SRF Limited is navigating a phase of strategic consolidation and leadership continuity amid fluctuating profitability. The company has demonstrated strong operational momentum with recent profit growth, yet faces elevated valuation multiples relative to peers. Management is focused on sustaining governance stability and capital efficiency while preparing for long-term capital deployment through debt issuance.

📰 What's Happening

In Q4 FY2026, SRF reported a 69.9% YoY surge in net profit to ₹1,000 crores, signaling robust earnings expansion. The company reappointed Kartik Bharat Ram as Joint Managing Director for a five-year term through March 31, 2031, and approved the re-appointment of Pramod Gopaldas Gujarathi as Whole Time Director, ensuring leadership continuity. Shareholders ratified cost auditor remuneration and authorized a private placement of up to ₹1,500 crores in redeemable non-convertible debentures, to be executed within one year post-AGM. The 55th AGM, held on June 30, 2026, underscored governance continuity and strategic capital planning ahead of FY2026-27.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue383,3383,1773,0533,5703,4643,4243,491
Operating Profit10708655585719629571659
OPM %24.7%20.9%19.7%18.5%19.5%17.4%15.7%17.8%
Net Profit6359301253422252201271
EPS₹18.97₹12.12₹10.15₹8.55₹14.24₹8.51₹6.79₹9.15

Operating performance has shown consistent improvement, with operating profit rising from ₹571 crores in Q2FY25 to ₹659 crores in Q3FY25, and net profit peaking at ₹422 crores in Q4FY24 before moderating to ₹271 crores in Q3FY25. While margins remain healthy, the sequential dip in profitability in the latest quarter may reflect macro headwinds or investment timing, though management has not flagged significant concerns. The strong base in FY2024, particularly the ₹719 crores operating profit in Q4FY24, suggests underlying resilience in core operations.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue or margin expectations in the reviewed filings. However, the reappointment of key leadership and authorization for ₹1,500 crores in debentures indicate a focus on long-term capital structure management. The board emphasized governance continuity and compliance, with no disclosed strategic expansion plans beyond routine capital allocation. Investor focus remains on execution of the upcoming debenture issuance and its impact on leverage and returns.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
Solar Industries India Limited 1.57 L Cr 132.3
Pidilite Industries Limited 1.49 L Cr 75.7
SRF Limited 79,723 69.5
Linde India Limited 62,701 141.9
Gujarat Fluorochemicals Limited 40,793 89.6
Navin Fluorine International Limited 35,894 131.5
Himadri Speciality Chemical Limited 30,071 56.6
Deepak Nitrite Limited 24,911 33.3
Atul Limited 20,904 48.8
Tata Chemicals Limited 19,079 -47.1

⚠️ Risk Factors

1. Elevated valuation (P/E of 69.5) relative to sector peers may limit upside despite strong earnings. 2. Dependence on cyclical chemical demand and foreign exchange volatility could pressure margins. 3. The planned ₹1,500 crores debenture issuance introduces refinancing and liquidity risks if market conditions deteriorate. 4. Leadership continuity is positive, but the family-led governance model may limit independent board oversight in future strategic decisions.

📋 Recent Filings

🧠 Analyst's Read

SRF Limited is transitioning into a phase of stable governance and capital planning, with recent earnings momentum supporting its valuation. Investors should monitor the execution of the debenture issuance and its impact on capital structure, as well as any shifts in foreign investor sentiment. The company's trajectory hinges on sustaining profitability amid macro volatility and translating leadership stability into long-term shareholder value.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when SRF files new disclosures

Track SRF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SRF — Free

Free account · 2 AI queries/day